Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedUpdated the site revision indicator from v3.4.2 to v3.4.3; the previous revision entry was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history shows addition of v3.4.2 and removal of v3.4.1; this is a minor maintenance update to the revision history and does not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedA minor site revision label was updated from v3.4.0 to v3.4.1 and does not affect study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedGlossary display added and metadata updates including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange Detected- Page revision updated from v3.3.3 to v3.3.4. This is a metadata/maintenance change with no visible impact on study content.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing California, Florida, Illinois, Massachusetts, New York, Pennsylvania, and Texas, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.